TrialInternational journal of clinical oncology2025

Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1.

Hideki Goto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.